Literature DB >> 26635405

ATL treatment: is it time to change?

Olivier Hermine1.   

Abstract

Mesh：

Year:  2015        PMID： 26635405     DOI： 10.1182/blood-2015-10-670489

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using machine learning.

Authors:  Mohadeseh Zarei Ghobadi; Rahman Emamzadeh; Elaheh Afsaneh
Journal:  BMC Cancer       Date:  2022-04-21       Impact factor: 4.638

2.  A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis.

Authors:  Mattia Vicario; Adriana Mattiolo; Barbara Montini; Maria Assunta Piano; Ilaria Cavallari; Alberto Amadori; Luigi Chieco-Bianchi; Maria Luisa Calabrò
Journal:  Front Microbiol       Date:  2018-06-13       Impact factor: 5.640

3.  Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality.

Authors:  M Artesi; A Marçais; K Durkin; N Rosewick; V Hahaut; F Suarez; A Trinquand; L Lhermitte; V Asnafi; V Avettand-Fenoel; A Burny; M Georges; O Hermine; A Van den Broeke
Journal:  Leukemia       Date:  2017-08-16       Impact factor: 11.528

4.  HTLV-1 basic leucine zipper factor protects cells from oxidative stress by upregulating expression of Heme Oxygenase I.

Authors:  Amanda W Rushing; Blake Rushing; Kimson Hoang; Stephanie V Sanders; Jean-Marie Péloponèse; Nicholas Polakowski; Isabelle Lemasson
Journal:  PLoS Pathog       Date:  2019-06-28       Impact factor: 6.823

5.  Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).

Authors:  Xin Xu; Matko Kalac; Michael Markson; Mark Chan; Joshua D Brody; Govind Bhagat; Rosalind L Ang; Diana Legarda; Scott J Justus; Feng Liu; Qingshan Li; Huabao Xiong; Adrian T Ting
Journal:  Cell Death Dis       Date:  2020-02-05       Impact factor: 8.469
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.